March 1, 2023
Nippon Chemiphar said on February 28 that it will award Nanjing Neiwa Faith Pharmaceutical the exclusive rights to its proprietary novel xanthine oxidoreductase inhibitor (XOR) NC-2500 in China. Under the deal, the Chinese company will be granted the exclusive rights...read more